These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 32986682

  • 1. The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.
    Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB.
    J Parkinsons Dis; 2020; 10(4):1515-1527. PubMed ID: 32986682
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Dopamine D1 Receptor Partial Agonist, PF-06669571, in Subjects with Idiopathic Parkinson's Disease.
    Gurrell R, Duvvuri S, Sun P, DeMartinis N.
    Clin Drug Investig; 2018 Jun; 38(6):509-517. PubMed ID: 29478239
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
    Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB.
    Biomolecules; 2023 May 12; 13(5):. PubMed ID: 37238699
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov 12; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial.
    Waters CH, Nausieda P, Dzyak L, Spiegel J, Rudzinska M, Silver DE, Tsurkalenko ES, Kell S, Hsu A, Khanna S, Gupta S.
    CNS Drugs; 2015 Apr 12; 29(4):341-50. PubMed ID: 25895021
    [Abstract] [Full Text] [Related]

  • 17. Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
    Ries V, Selzer R, Eichhorn T, Oertel WH, Eggert K, German Tolcapone Study Group.
    Clin Neuropharmacol; 2010 May 12; 33(3):142-50. PubMed ID: 20502133
    [Abstract] [Full Text] [Related]

  • 18. Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease.
    Morales-Briceño H, Mahant N, Duma S, Martin A, Griffith J, Tsui D, Fung VS.
    Parkinsonism Relat Disord; 2019 Aug 12; 65():282-283. PubMed ID: 31221564
    [No Abstract] [Full Text] [Related]

  • 19. Pergolide : A Review of its Pharmacology and Therapeutic Use in Parkinson's Disease.
    Markham A, Benfield P.
    CNS Drugs; 1997 Apr 12; 7(4):328-40. PubMed ID: 27520755
    [Abstract] [Full Text] [Related]

  • 20. A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease.
    Farbman ES, Waters CH, LeWitt PA, Rudzińska M, Klingler M, Lee A, Qian J, Oh C, Hauser RA.
    Parkinsonism Relat Disord; 2020 Dec 12; 81():144-150. PubMed ID: 33130477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.